As Incyte Corporation continues its growth momentum thanks to JAK inhibitors Jakafi and Opzelura, the company is bringing its ...

Asymchem Laboratories is expanding its global footprint by taking on Pfizer’s leftovers in Sandwich, England. | Pfizer ...

Three years into a Senate Finance Committee investigation into Big Pharma’s tax strategies, committee chair Ron Wyden, ...

A new survey from Dexcom suggests that living with Type 2 diabetes can have significant impacts not only on physical health ...

A decade ago, with AstraZeneca in decline and some investors urging the drugmaker to sell out to Pfizer, new CEO Pascal ...

Even as GSK defends itself against thousands of personal injury lawsuits relating to its sale of heartburn pill Zantac, a ...

Following last year’s hard-won ulcerative colitis nod for Eli Lilly’s Omvoh, also known as mirikizumab, the ...

The biologics market for inflammatory bowel disease is continually getting more competitive, and now Johnson & Johnson’s ...

Havas is rebranding its health network, launching new global agencies as part of a reshuffle that will put most of its groups ...

Japan’s Astellas Pharma and Yaskawa Electric Corporation inked an agreement to explore the development of an automated cell ...

At the American Thoracic Society (ATS) international conference in San Diego, one of the major themes is the advance of new ...

As some industry efforts to deliver vaccines to Africa have fallen by the wayside, Serum Institute of India (SII), together ...